David Cicilline actually said...
And Mr. Balto also argued that PBMs exclusivity arrangements with some drug manufacturers can keep drug prices artificially high by keeping lower-price drugs off the market and by incentivizing PBMs through manufacturer rebates to switch patients from prescribed drugs to more expensive alternatives.
Context
Cicilline references Balto's argument about PBMs and drug pricing.
11/16/2015